Citadel Advisors
CGEM icon

Citadel Advisors’s Cullinan Oncology CGEM Stock Holding History

Citadel Advisors’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.59M Buy
252,778
+142,461
+129% +$1.83M ﹤0.01% 4917
2025
Q4 		$1.14M Sell
110,317
-1,874,090
-94% -$16.9M ﹤0.01% 7100
2025
Q3 		$11.8M Sell
1,984,407
-629,286
-24% -$4.61M 0.01% 3024
2025
Q2 		$19.7M Sell
2,613,693
-133,452
-5% -$1.07M 0.02% 2154
2025
Q1 		$20.8M Buy
2,747,145
+64,241
+2% +$616K 0.02% 1994
2024
Q4 		$32.7M Buy
2,682,904
+727,647
+37% +$10.5M 0.03% 1663
2024
Q3 		$32.7M Buy
1,955,257
+12,118
+0.6% +$215K 0.03% 1595
2024
Q2 		$33.9M Buy
1,943,139
+833,968
+75% +$17.8M 0.03% 1494
2024
Q1 		$18.9M Sell
1,109,171
-23,718
-2% -$366K 0.02% 2126
2023
Q4 		$11.5M Buy
1,132,889
+67,841
+6% +$601K 0.01% 2649
2023
Q3 		$9.64M Buy
1,065,048
+8,697
+0.8% +$90.6K 0.01% 2726
2023
Q2 		$11.4M Buy
1,056,351
+433,283
+70% +$4.6M 0.01% 2510
2023
Q1 		$6.37M Buy
623,068
+377,958
+154% +$4.17M 0.01% 3423
2022
Q4 		$2.59M Buy
245,110
+9,507
+4% +$115K ﹤0.01% 5010
2022
Q3 		$3.02M Sell
235,603
-133,867
-36% -$1.8M ﹤0.01% 4797
2022
Q2 		$4.74M Buy
369,470
+229,785
+165% +$2.61M 0.01% 3896
2022
Q1 		$1.46M Buy
139,685
+93,204
+201% +$1.26M ﹤0.01% 6791
2021
Q4 		$717K Sell
46,481
-59,652
-56% -$1.19M ﹤0.01% 8772
2021
Q3 		$2.4M Buy
106,133
+3,025
+3% +$80.9K ﹤0.01% 5905
2021
Q2 		$2.65M Sell
103,108
-8,214
-7% -$253K ﹤0.01% 5899
2021
Q1 		$4.64M Buy
+111,322
New +$4.52M ﹤0.01% 4411

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return